BioNexus Gene Lab
BGLC
#10176
Rank
โ‚ฌ5.98 M
Marketcap
0,33 โ‚ฌ
Share price
-2.83%
Change (1 day)
-27.09%
Change (1 year)

BioNexus Gene Lab (BGLC) - Cash on Hand

Cash on Hand as of September 2024 : โ‚ฌ4.01 Million

According to BioNexus Gene Lab's latest financial reports the company has โ‚ฌ4.01 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioNexus Gene Lab - Cash on Hand chart (from 2019 to 2024)

20202021202220232024โ‚ฌ1Mโ‚ฌ2Mโ‚ฌ3Mโ‚ฌ4Mโ‚ฌ5Mโ‚ฌ6Mcompaniesmarketcap.com

Cash on Hand by year

Year Cash on Hand Change
2022-12-31โ‚ฌ1.97 M5.33%
2021-12-31โ‚ฌ1.87 M-17.25%
2020-12-31โ‚ฌ2.26 M195.54%
2019-12-31โ‚ฌ0.76 M-30.39%
2018-12-31โ‚ฌ1.1 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ0.26 B 6,483.38%๐Ÿ‡บ๐Ÿ‡ธ USA